← FDA WARNING LETTERS
FDA WARNING LETTER8 March 2017

SUCESORES DE ESMORIS — FDA Warning Letter

Company
SUCESORES DE ESMORIS
Letter date
8 March 2017
CHECKING ACCESS

Checking your Professional access…

DON’T BE THE NEXT LETTER
Assess your quality systemBaseline against 12 GxP domains in 10 minutes →Decode the standardsThe requirements behind the citations →All warning lettersBrowse the live FDA feed →

Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.